140 related articles for article (PubMed ID: 7929528)
21. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.
Nagy A; Schally AV; Armatis P; Szepeshazi K; Halmos G; Kovacs M; Zarandi M; Groot K; Miyazaki M; Jungwirth A; Horvath J
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7269-73. PubMed ID: 8692981
[TBL] [Abstract][Full Text] [Related]
23. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
[TBL] [Abstract][Full Text] [Related]
24. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
Leuschner C; Enright FM; Gawronska B; Hansel W
Breast Cancer Res Treat; 2003 Mar; 78(1):17-27. PubMed ID: 12611453
[TBL] [Abstract][Full Text] [Related]
25. Long-term inhibition of ovulation by a GnRH-antagonist at low dose level.
Kovacs M; Mezo I; Flerko B; Teplan I; Nikolics K
Biochem Biophys Res Commun; 1984 Jan; 118(1):351-5. PubMed ID: 6365100
[TBL] [Abstract][Full Text] [Related]
26. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
[TBL] [Abstract][Full Text] [Related]
27. Analogues of luteinizing hormone-releasing hormone containing cytotoxic groups.
Janáky T; Juhász A; Bajusz S; Csernus V; Srkalovic G; Bokser L; Milovanovic S; Redding TW; Rékási Z; Nagy A
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):972-6. PubMed ID: 1310542
[TBL] [Abstract][Full Text] [Related]
28. Influence on antiproliferative activity of structural modification and conjugation of gonadotropin-releasing hormone (GnRH) analogues.
Kálnay A; Pályi I; Vincze B; Mihalik R; Mezõ I; Pató J; Seprõdi J; Lovas S; Murphy RF
Cell Prolif; 2000 Oct; 33(5):275-85. PubMed ID: 11063130
[TBL] [Abstract][Full Text] [Related]
29. Short-chain analogs of luteinizing hormone-releasing hormone containing cytotoxic moieties.
Janáky T; Juhász A; Rékási Z; Serfözö P; Pinski J; Bokser L; Srkalovic G; Milovanovic S; Redding TW; Halmos G
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10203-7. PubMed ID: 1332035
[TBL] [Abstract][Full Text] [Related]
30. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
Krebs LJ; Wang X; Pudavar HE; Bergey EJ; Schally AV; Nagy A; Prasad PN; Liebow C
Cancer Res; 2000 Aug; 60(15):4194-9. PubMed ID: 10945629
[TBL] [Abstract][Full Text] [Related]
31. Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.
Neri C; Colomb E; Roux-Dosseto M; Martin PM
Anticancer Res; 1991; 11(1):411-5. PubMed ID: 1826824
[TBL] [Abstract][Full Text] [Related]
32. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats.
Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM
J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616
[TBL] [Abstract][Full Text] [Related]
33. Agonists and antagonists of GnRH-I and -II reduce metastasis formation by triple-negative human breast cancer cells in vivo.
Schubert A; Hawighorst T; Emons G; Gründker C
Breast Cancer Res Treat; 2011 Dec; 130(3):783-90. PubMed ID: 21279682
[TBL] [Abstract][Full Text] [Related]
34. Gonadotropin-releasing hormone (GnRH)-binding sites in human breast cancer cell lines and inhibitory effects of GnRH antagonists.
Eidne KA; Flanagan CA; Harris NS; Millar RP
J Clin Endocrinol Metab; 1987 Mar; 64(3):425-32. PubMed ID: 3029154
[TBL] [Abstract][Full Text] [Related]
35. Gonadotropin-releasing hormone analogs inhibit primate granulosa cell steroidogenesis via a mechanism distinct from that in the rat.
Wickings EJ; Eidne KA; Dixson AF; Hillier SG
Biol Reprod; 1990 Aug; 43(2):305-11. PubMed ID: 2165826
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207.
Plonowski A; Schally AV; Nagy A; Groot K; Krupa M; Navone NM; Logothetis C
Cancer Lett; 2002 Feb; 176(1):57-63. PubMed ID: 11790454
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
Yano T; Pinski J; Radulovic S; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1701-5. PubMed ID: 8127868
[TBL] [Abstract][Full Text] [Related]
38. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines.
Emons G; Schröder B; Ortmann O; Westphalen S; Schulz KD; Schally AV
J Clin Endocrinol Metab; 1993 Dec; 77(6):1458-64. PubMed ID: 8263128
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth of human ovarian cancer in nude mice by luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75).
Manetta A; Gamboa-Vujicic G; Paredes P; Emma D; Liao S; Leong L; Asch B; Schally A
Fertil Steril; 1995 Feb; 63(2):282-7. PubMed ID: 7843432
[TBL] [Abstract][Full Text] [Related]
40. Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75.
Kleinman D; Roberts CT; LeRoith D; Schally AV; Levy J; Sharoni Y
Regul Pept; 1993 Oct; 48(1-2):91-8. PubMed ID: 8265821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
